SARS-CoV-2 IgG/IgM Rapid Test Kit Intended Use: To detect IgM and IgG antibodies against N and S protein of SARS-CoV-2 in whole blood, serum and plasma Product Format: 25 tests/kit Kit Contents: test card, diluent, capillary, lancet, and instruction for use. Storage/Stability: 2 C to 30C for 12 months.� eproducibility /Precision 100% Concordant across 3 lots with CV ±5% Performance Comparison (A) China Validation Test Positive Samples 100 / 102 Sensitivity: 98.04% Negative Samples 491/492 Specificity: 99.80% Overall Accuracy: 99.49% Performance Comparison (B) Positive Samples 23 / 25 Sensitivity: 92% Negative Samples 25 / 25 Specificity: 100% Overall Accuracy: 96%
20 tests/box
covid antigen nasal rapid test passed the Germany PEI testing and registered on EU Common List
20 tests/box, 1 pcs/box, 5pcs/box
For in vitro qualitative detection of SARS-CoV-2 nucleocapsid antigen in nasal (NS) swab specimens directly from individuals who are suspected of COVID-19 by their healthcare provider within the first 5 days after onset of symptoms. This test is only provided for use by clinical laboratories or to healthcare workers for point-of-care testing, not for at-home testing. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, or 2019-nCoV) is an enveloped non-segmented positive-sense RNA virus. It is the cause of coronavirus disease (COVID-19), which is contagious in humans. SARS-CoV-2 has several structural proteins including spike (S), envelope (E), membrane (M), and nucleocapsid (N). The antigen is generally detectable in upper respiratory samples during the acute phase of infection. Positive results indicate the presence of viral antigens, but the clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out a bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease. Negative results should be treated as presumptive, which do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient's recent exposures, history, and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. For in vitro diagnostic use only. For professional use only .
1. Nasopharynx swab specimen, non-invasive 2. Very simple to use 3. Convenient, no devices required 4. Rapid, results within 20 minutes 5. Cost-efficient 6:Listed on German BfArm ,got approval by PEI Clinical report from local CDC Sensitivity is 97.14%, Specificity is 100%, total accuracy rate is 99.68%.
The product is based on the principle of antigen-antibody reaction and immunoassay technique. The test device contains colloidal gold labeled SARS-CoV-2 recombinant protein, mouse-anti human IgG antibody immobilized in G test area, mouse-anti human IgM antibody immobilized in M test area and the corresponding antibody in quality control area (C). During the test, when the SARS-CoV-2 IgM antibody level in the sample is at or above the limit of detection of the test, the SARS-CoV-2 IgM antibody in the sample binds to the colloidal gold labeled SARS-CoV-2 recombinant protein which is pre-coated on a gold label pad. The conjugates migrate upward through capillary effect and would be captured by mouse-anti human IgM antibody immobilized in M test area subsequently and this produces a purple-red band appears in the M test area. When the SARS-CoV-2 IgG antibody level in the sample is at or above the limit of detection of the test, the SARS-CoV-2 IgG antibody in the sample binds to the colloidal gold labeled SARS-CoV-2 recombinant protein which is pre-coated on a gold label pad. Theconjugates migrate upward through capillary effect and would be captured by mouse-anti human IgG antibody immobilized in G test area subsequently and this produces a purple-red band appears in the G test area. If it is a negative sample, there is not a purple-red band appeared in the M and G test area. Regardless of the presence or absence of the SARS-CoV-2 antibody in the sample, a purple-red band will appear in the quality control area (C). The purple-red band in the quality control area (C) is a criterion for judging whether there is enough sample and whether the chromatography process is normal. It also serves as the internal control standard for reagents.
Product Details: Usage/Application Hospital Time To Result 5-10 min SD BIOLINE Strep A rapid test is a chromatographic immunoassay for the qualitative detection of group A streptococcal antigens directly from throat swabs or confirmation of presumptive Group A Streptococcal colonies recovered from culture. Detection of strep-A antigen directly from throat swab Easy to use: throat swab sample Optimal test for Group A streptococcal infection. Ordering Information Cat No. Description Specimen Pack Size 45FK12 Strep A Group A Throat swab 25 Tests Streptococcal Ag
INTENDED USE The One Step Dengue NS1 Ag Test is a rapid chromatographic immunoassay for the qualitative detection of dengue virus NS1 antigen in serum or plasma to aid in the diagnosis of Dengue viral infection. SUMMARY Dengue is transmitted by the bite of an Aedes mosquito infected with any one of the four dengue viruses. It occurs in tropical and sub-tropical areas of the world. Symptoms appear 3 14 days after the infective bite. Dengue fever is a febrile illness that affects infants, young children and adults. Dengue haemorrhagic fever (fever, abdominal pain, vomiting, bleeding) is a potentially lethal complication, affecting mainly children. Early clinical diagnosis and careful clinical management by experienced physicians and nurses increase survival of patients. One step Dengue NS1 Ag Test is a simple, visual qualitative test that detects dengue virus NS1 antigen in human serum or plasma. The test is based on immunochromatography and can give a result within 15 minutes. 25PCS/BOX
Specification Strength/ Size Packing Size Packed In HBsAg Rapid Card Test 50 Tests 50 Box Pack
The self testing product is transformed from the professional testing product CLUNGENE COVID 19 Antigen Rapid Test manufactured by Clongene The BfArM has granted the first special approvals according to 11 paragraph 1 of the German Medical Devices Act ( of antigen tests for self administration by laypersons (self tests) for the detection of SARS CoV 2 Our self testing product can be sold and used in Germany Overview of CLUNGENE COVID 1
INTENDED USE The Helicobacter-Pylori antigen rapid test kit (stool) is a rapid visual immunoassay for the qualitative detection of helicobacter pylori antigen in human stool specimens. This kit is used as an aid in the diagnosis of H. pylori infection. INTRODUCTION Helicobacter pylori (also known as Campylobacter pylori) as a spiral-shaped gram negative bacteria which infects the gastric mucosa. H. pylori to causes several gastro-enteric diseases such as non-ulcerous dyspepsia, gastric and duodenal ulcer, active gastritis and can even increase the risk of stomach adenocarcinoma. The epidemiologic study shows that more than 50% of the world's population is infected by H. pylori strains. Infection is more prevalent in developing countries. The lowest infection rate is 20%, and the highest infection rate can be 90% in developing countries. H. pylori strains is the major reason to cause chronic gastritis and gastric ulcers, 80%-90% chronic gastritis patients and 95%-100% gastric ulcers patients are infected by H. pylori strains. So the detection and treatment of H. pylori strains infection is very important. At present several invasive and non-invasive approaches are available to detect this infection state. Invasive methodologies require endoscopy of the gastric mucosa with histologic, cultural and urease investigation, which are expensive and require some time for diagnosis. Alternatively, non-invasive methods are available such as breath tests, which are extremely complicated and not highly selective, and classical ELISA and immunoblot assays. This Kit belongs to non-invasive approach.
USA Manufactured, highly accurate, rapid COVID-19 Antigen test. Clinically validated by third-party medical institutions in USA and Europe (Denmark, Poland). The test is highly specific and sensitive (Specificity 100%, Sensitivity 99.1%). Manufacturer has a decade of experience in rapid testing. Available in either bulk or home-use packaging. Manufcatured and ships out of Miami, Florida.
USA Manufactured, highly accurate, rapid COVID-19 Antibody test. Clinically validated in the USA by Harvard and UCSF Universities, and found to be best-in-class of Antibody tests. 95-100% accuracy in identifying patients after days 12. Manufacturer has a decade of experience in rapid testing. Available in either bulk or home-use packaging. Manufcatured and ships out of Miami, Florida.
25 Piece SKU: 4314-25 EAN: 4250415677038 clinical specificity = 100 % clinical Sensitivity = 98,5 % BfArM approval fast and reliable test results in only 15 minutes can be performed with naso- and oropharyngeal samples all test components are included
Product Name Neutrophil Gelatinase-Associated Lipid Carrier Protein (NGAL)Test Kit (Immunofluorescence Chromatography) Purpose To detect the NGAL in human plasma/serum/whole blood in vitro quantitatively.For Professional Use only. Principles of Detection The NGAL Test is a fluorescent lateral flow immunoassay. The test consists of: 1) a conjugate pad containing NGAL antibody conjugated with fluorescent microspheres and a control antibody (goat anti-chicken IgY antibody) conjugated with fluorescence microspheres, 2) a nitrocellulose membrane strip containing a test line (T line) and a control line (C line). The T line is pre-coated with anotherNGAL antibody, and the C line is pre-coated with a control line antibody (chicken IgY antibody). NGAL concentration in specimen is positively correlated with the fluorescent density of the microspheres, after the measure and calculation of the quantitative fluorescence immunoassay analyzer, then the analyzer would calculate the concentration of NGAL according to the preset calibration curve in the machine and display the result, detection unit is ng/mL. C line should appear in any cases, which indicates the reaction system is effective. Reference range Reference value: 37-180ng/mL; The reference value is verified by referring to similar products on the market. Due to ethnic and regional differences, each laboratory can establish its own reference interval according to the actual situation.
1) Zhenrui (Immediate Stock) at HKD65 per test 2) Newgene (available in 3-5 days upon order) at HKD30 per test 3) Aripa (available on 22 Feb 2022) at HKD68 per test 4) Healgen (available in 1-2 weeks) at HKD48 per test 5) Giant King (available in 1-2 weeks) at HKD48 per test 6) BioTeke (immediate available - 1M) at HKD30 per test 7) TBG (MOQ : 1M) at USD4.50 per test
Antigen Detection Rapid Lateral Flow Test (latex bead-based) AIVD Biotech's Ag test is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein (NP) antigen in direct nasal swabs from individuals suspected of infection. Description: This kit utilizes the principle of latex bead immunochromatography to qualitatively detect the Np antigen in human nasal swabs. Lateral flow immunochromatographic assay provides an easy workflow, short turnaround time, and rapid diagnosis of suspected patients. The test contains latex bead conjugate pad and a membrane strip pre-coated with antibodies specific to the antigen on the test lines (T). If novel NP antigen is present in the specimen, a visible band appears on the test lines (T) as antibody-antigen-antibody latex bead complex forms. The control line (C) is used for procedural control and should always appear if the test is performed correctly. This method does not require expensive medical instruments and consumables. Just take the specimen and add it to the sample well. If sample contains the antigen, it will interact with the latex bead-labeled anti- NP antibodies on the conjugate pad. Required components 1. A foil pouch with a desiccant and a single use test card, 1 piece 3. Sterile swab, 1 piece 3. Extraction buffer tube (1 ml), 1 tube. 4. Instructions for use, 1 piece. Storage conditions 1. Store at the dark place, room temperature 18~28C with low humidity. 2. After opening the foil bag, please use the test cassette within 30 mins. 3. Expiration period 12 month Specimen requirements: 1. Nasopharyngeal swab specimen. 2.Specimen should be tested as soon as possible upon collection. If the sample has to be stored, store the swab sample at room temperature for up to 1 hour or 2~8C for up to 4 hours prior to testing. Performance Characteristics A total of 365 samples from suspected patients were tested by the RT-qPCR test. Testing results are shown in the following table: PCR AIVD Antigen Rapid Test Kit Positive Negative Positive 59 8 Negative 6 292 Total: 65 300 Sensitivity: 90.7%; Specificity: 97.3%.
500k Landed in NY weekly. Connected to second largest Sienna distributor in North America. Carton Pricing starts at $4.50. Message for Pallet and up pricing. PO-POL-Invoice-Wire-Ship/Pick Up
Our products are directly from factories, Boson, H-Guard, Flow flex, etc.
